miR-130a Upregulates mTOR Pathway by Targeting TSC1 and Is Transactivated by NF-κB in High-Grade Serous Ovarian Carcinoma

Cell Death and Differentiation - United Kingdom
doi 10.1038/cdd.2017.129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-1236-3p Represses the Cell Migration and Invasion Abilities by Targeting ZEB1 in High-Grade Serous Ovarian Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

Retinoblastoma Pathway Deregulatory Mechanisms Determine Clinical Outcome in High-Grade Serous Ovarian Carcinoma

Modern Pathology
Forensic MedicinePathology
2013English

The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma

2019English

Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

HMGA2: A Biomarker Significantly Overexpressed in High-Grade Ovarian Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2010English

Erratum To: Tubal Precursor Lesions in High Grade Serous Ovarian Carcinoma

Indian Journal of Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Figure 4: NF-κB Heterodimer Expression: High Grade Urothelial Carcinoma.

English

Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy